Doctors at the Frankfurt University Hospital said the patient, who was medically evacuated to Frankfurt after working with Ebola victims in Sierra Leone, recovered after receiving the drug called FX06, developed by scientists at the Vienna General Hospital in Austria.
Rather than attacking the virus, the Frankfurt hospital said the treatment focused on mitigating the damage to organs caused by the pathogen
“Patients need to survive for 10 to 12 days until their body has enough time to develop antibodies to Ebola,” said Timo Wolf, the infectious diseases specialist who treated the patient
“Potential Ebola treatments include Avigan, or favipiravir, from Japan’s Fujifilm, which was originally developed as a flu drug; a medicine called ZMapp developed by Mapp Biopharmaceuticals in the United States; and a fourth potential drug called TKM-Ebola, being developed by Tekmira.”
Further confirmation that allopathic (conventional) doctors are wedded to the corporate (expensive) solutions.